Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Recruiting

NG2 and DLL3 CAR-T Cells Targeting Melanoma

NCT07193966

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China

View Trial Details

Recruiting

Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma

NCT07195500

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +10 more
Locations: Nanjing First Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread

NCT07193654

Conditions: Astrocytoma, Central Nervous System Neoplasms, Glioblastoma, +14 more
Locations: 2nd Affiliated Hospital, School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

NCT05941507

Conditions: Adnexal Diseases, Advanced Solid Tumors, Anus Diseases, +60 more
Locations: Cedars Sinai Medical Center Los Angeles, California, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

University of Michigan Ann Arbor, Michigan, United States

Tennessee Oncology Nashville, Tennessee, United States

View Trial Details

Recruiting

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

NCT06805825

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Albinism, +58 more
Locations: University of Michigan Hospitals Ann Arbor, Michigan, United States

Case Comprehensive Cancer Center Cleveland, Ohio, United States

Oregon Health & Science University Portland, Oregon, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma

NCT05532397

Conditions: Astrocytoma, Glioma, Glioma, Astrocytic, +7 more
Locations: Department of Hematology-Oncology, National University Hospital Singapore

Ng Teng Fong General Hospital Singapore

View Trial Details

Recruiting

Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas

NCT04772456

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Rosy Njonkou Tchoquessi Baltimore, Maryland, United States

View Trial Details

Recruiting

PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)

NCT07185672

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +6 more
Locations: Tata Memorial Hospital, Mumbai, India Mumbai, Maharashtra, India

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Navi Mumbai, Maharashtra, India

View Trial Details

Recruiting

GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma

NCT03294954

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Study of How Safe and Effective Tarlatamab is in Brain Cancers

NCT06776250

Conditions: Astrocytic Tumor, Astrocytoma, Glioma, +8 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions